Interferon-alpha + interferon-beta - GeneTrol Biotherapeutics
Alternative Names: OncoKine; OncoKine ILatest Information Update: 16 Jul 2016
At a glance
- Originator GeneTrol Biotherapeutics
- Class
- Mechanism of Action Interferon alpha stimulants; Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malignant melanoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malignant-melanoma in USA
- 29 Oct 2001 Preclinical development for Malignant melanoma in USA (Unknown route)